ONWRY.US Onward Medical N.V.
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is ONWRY.US undervalued?
Graham numberThe Graham number of Onward Medical N.V. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Onward Medical N.V. fundamental analysis
No fundamental analysis for Onward Medical N.V. yet.
Onward Medical N.V. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implan…
Full company profileFinancial statements of Onward Medical N.V. are not available yet.
Onward Medical N.V. dividends
Onward Medical N.V. has not paid dividends in the last 3 fiscal years.
Who owns Onward Medical N.V.
Ownership data of Onward Medical N.V. is not available yet.
Onward Medical N.V. company profile
- Company name
- Onward Medical N.V.
- Ticker
- ONWRY.US
- Exchange
- USA Stocks
- Sector
- -
- Industry
- -
- Employees
- 137
- Fiscal year end
- December
- Address
- Schimmelt 2, Eindhoven, Netherlands, NL-5611
- Website
- onwd.com
About Onward Medical N.V.
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V. management
10- Mr. David L. MarverCEO & Executive Director · born 1968
- Dr. Gregoire Courtine Ph.D.Co-Founder & Senior Advisor · born 1975
- Mr. Ali KiboroChief Financial Officer · born 1976
- Mr. Robert W. OdellVice President of Operations · born 1960
- Mr. Lorenzo FantiVice President of Legal
- Mr. Sebastien CrosVice President of Communications
- Mr. Alexandre CasteauHead of Strategy & Corporate Development
- Ms. Julie CromDirector of People & Culture
- Mr. Sean SciaraChief Commercial Officer
- Ms. Shari O'QuinnChief Clinical, Regulatory & Quality Officer